Neoplasia 1 Flashcards

1
Q

a tumour

A

a swelling (any clinical detectable lump or swelling)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

neoplasm

A

‘ a neoplasm is an abnormal growth of cells that persists after the initial stimulus is removed’ - new growth - just one type of tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

oncology

A

study of tumours and neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hyperplasia

A

increase in cell number

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hypertrophy

A

increase in cell size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

regeneration

A

return to normal mechanisms e.g. the liver

  • stimulated by GF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

benign neoplasia

A

gross and microscopic appearances are considered to be innocent, implying that it will remain localised and not spread to other sites

  • less well differentiated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cancer

A

a malignant neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

neoplasm

A

an abnormal growth of cells that persists after the initial stimulus and invades surrounding tissues with the potential to spread to distant sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

metastasis

A

where a malignant neoplasm has spread from its original site to a new non-contiguous site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dysplasia

A

A pre-neoplastic alteration in which the cells how disordered tissue organisation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

characteristics of dysplasia

A

Reversible

Can exhibit considerable pleomorphism, with large hyperchromatic nuclei and high nuclear to cytoplasmic ratio

If detected early it can be prevented from progressing to cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

summary of how a tumour can be defined

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primary site

A

original location of malignant neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

secondary site

A

place to which it has spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do we tell the difference between benign and malignant tumours

A
  1. Behaviour of the tumour
    • E.g. if its metastases = probably malignant
  2. Appears different to the naked eye
  3. Differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

behaviour of benign neoplasms

A
  • remain confined to their site of origin and do not produce metastases
  • Grow in a confined area- capsule
  • Pushing outer margin
  • Rarely dangerous (depends on location)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

where could a benign tumour be dangerous

A

in the brain- confined space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

behaviour of malignant neoplasms

A
  • invade and have the potential to metastasise
  • Irregular outer margin and shape
  • May have ulcerations and necrosis
  • Infiltrative
  • Grow very rapidly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

definititon of differentitation

A

process of becoming different by growth or differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

differentitation and benign tumours

A

closely resemble the parent tissue- well differentiated

23
Q

differentiation and malignant neoplasms

A

range from well to poorly differentiated dependent on how closely they resemble the cell origin

24
Q

cells with no resemblance to any tissue are called

A

anaplastic

25
characteristics of poorly differentiated cells (6)
1. Increased nuclear size 2. Increases nuclear to cytoplasmic size 3. Increased nuclear staining (hyperchromasia) 4. Increased mitotic figures 5. Abnormal mitotic figures 6. Variation in size and shape of cells and nuclei (pleomorphism)
26
what term do clinicians use to indicate differentition
grade - a high grade tumour is usually poorly differentiated
27
melanoma
- poorly differneited - pigment= melanin
28
summary of behaviour of benign tumour
- grows locally - retained functions of their cells of origin
29
histology of benign tumour
- resembles cells/tissue of origin - few mitoses - normal or mild increase in nuclear to cytoplasmic ration - cells are unifrom throughout the tumour
30
summary of behaviour of malignant tumour
- expansive and invasive - potential to metastasise - less likely to retain functions of cells of origin and may soemtimes acquired unexpected functions
31
histology of malignant tumour
- failure ot fully differentiate - many mitoses - high nuclear to cytoplasmic ration - cells/ nuceli vary in size and shape (pleomorphism)
32
pleomorphism
cells/ nuceli vary in size and shape
33
example of grade
grade 1- well differentiated grade 3- poorly differnetiated
34
gradding pattern for the breast
Gleasons pattern
35
the higher the grade
the less liekly to survive
36
dysplasia and differentiation
## Footnote Altered differentiation Not yet invasive Mild, moderate and severe- worsening differentiation
37
Dysplasia in the cervice
**CIN1-** mild dysplasia Malignant changes just affecting lower third of epithelium **CIN2-** moderate dysplasia Lower 2/3rd **CIN3-** severe dysplasia Full thickness of the epithelium
38
why do we get neoplasia (2)
1. Cacrinogenesis 2. Non-lethal genetic damage (can be genetic, can be spontaneous, can be environmental)
39
mutations and neoplasia
* Accumulated mutations in somatic cells * Mutations are caused by initiators- mutagenic agents * Promoters then cause cell proliferation * A tumour is formed by the clonal expansion of a single precursor cell that has incurred genetic damage
40
give 4 intiators
* Chemicals * smoking * alcohol * diet and obesity * Infectious agents * HOV * Radiation * Inherited mutation
41
progression of a normal cell to neoplastic cells due to mutation
1) normal cell population 2) Intiator causes mutation in one cell 3) Mitosis of cell and vertical transmsision of mutation 4) most cells start to have mutation
42
germline mutations
e.g. BRCA1 skips out this progressing stage\*
43
a selection of cell is monoclonal if
they all originated from a single founding cell
44
neoplasms emerges from
this group of cells by a process called progression - characterised by an accumulation of more mutations - mutations may give the cell advanatges such as faster growth
45
4 classes of normal regulatory genes
* Growth promoting **proto-oncogenes** * Growth inhibiting **tumour suppressor genes** * Genes that regulated programmed cell death – **apoptosis** * Genes involved in **DNA repair**
46
proto-oncogenes
- participate in signalling pathwyas which drive proliferation - '**increase in function' mutation** - when mutated become **Oncogenes**
47
oncoge
48
oncogenes
* are created by mutations in proto-oncogenes and encode proteins called oncoproteins that have the ability to promote cell growth in the absence of normal growth promoting signals * They can transform cells despite a normal copy of the same gene * **Oncogenes are dominant over their normal counterparts (allele)**
49
oncogene mutations can be targeted by
inhibitors eg.g. BRAF inhibitor - therefoe eimportnant to identify oncogene causing cancer
50
tumour suppressor genes
* Normal function is to stop cell proliferation * Generally cause a **loss of function** * In most instances **both alleles** must be damaged for transformation to occur * Abnormalities in these genes leads to failure of growth inhibition (e.g. TP53)
51
apoptosis regulating genes
* May acquire abnormalities that result in less cell death and enhanced survival of mutated cells * E.g. follicular B cell lymphoma
52
DNA repair genes
* Loss of function mutations * Contribute indirectly to carcinogenesis * Impair the ability of cell to recognise and repair non-lethal genetic damage in other genes * As a result affected cells acquire mutations at an accelerated rate, a state referred to as a mutator phenotype and is marked by genomic instability
53